Last update :
16/06/2024
References   References 4790  
Type : Journal
Web link : https://doi.org/10.1186/s40942-023-00507-3

Research teams : Oslo - Oslo University Hospital
Authors : Jørstad Ø.K, Foss S, Gjølberg T.T, Mester S, Nyquist-Andersen M, Sivertsen M.S, Fossum D, Gleditsch E, Moe M.C, Andersen J.T.
Title : Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Reference : Int J Retina Vitreous ; 9:65. 2023

Level of Evidence : 
Level of evidence B+
Physical stability : 
Size Exclusion Chromatography 
Chemical stability : 
Capillary electrophoresis
Other methods : 
Comments : 
Proteins: biological activity by enzymatic technique

List of drugs
InjectionFaricimab Various
Stability in solutions Polypropylen Syringe None 120 mg/ml 4°C Light
37 Day

  Mentions Légales